Qube Research & Technologies (QRT)
LHDX

Qube Research & Technologies (QRT)’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-58,790
Closed -$210K – 3307
2022
Q1 		$210K Sell
58,790
-5,939
-9% -$29.2K ﹤0.01% 1930
2021
Q4 		$557K Buy
+64,729
New +$412K ﹤0.01% 1507

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
CWA
Choice Wealth Advisors Waterville, Maine $285M AUM 19.08% 1-Year Est. Return
CWA
Consilio Wealth Advisors Bellevue, Washington $417M AUM 20.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LHDX Position: Q2 2022 in Review

Qube Research & Technologies (QRT) sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2022, closing a stake of 58,790 shares — an estimated $210K sold.

Qube Research & Technologies (QRT) first reported a position in LHDX in Q4 2021 and held it in 2 quarters. The position peaked at $557K in Q4 2021. 38 funds tracked by Wall St. Rank hold LHDX as of Q2 2022.

  • Qube Research & Technologies (QRT) reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 58,790 Lucira Health, Inc. Common Stock shares in Q2 2022, an estimated $210K.
  • Qube Research & Technologies (QRT) first reported a position in Lucira Health, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Lucira Health, Inc. Common Stock position peaked at $557K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2022, filed 15 Aug 2022.